1. Home
  2. NVAX vs RDFN Comparison

NVAX vs RDFN Comparison

Compare NVAX & RDFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • RDFN
  • Stock Information
  • Founded
  • NVAX 1987
  • RDFN 2002
  • Country
  • NVAX United States
  • RDFN United States
  • Employees
  • NVAX N/A
  • RDFN N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • RDFN Real Estate
  • Sector
  • NVAX Health Care
  • RDFN Finance
  • Exchange
  • NVAX Nasdaq
  • RDFN Nasdaq
  • Market Cap
  • NVAX 1.3B
  • RDFN 1.1B
  • IPO Year
  • NVAX 1995
  • RDFN 2017
  • Fundamental
  • Price
  • NVAX $8.17
  • RDFN $10.50
  • Analyst Decision
  • NVAX Buy
  • RDFN Hold
  • Analyst Count
  • NVAX 6
  • RDFN 10
  • Target Price
  • NVAX $17.83
  • RDFN $9.81
  • AVG Volume (30 Days)
  • NVAX 4.7M
  • RDFN 13.9M
  • Earning Date
  • NVAX 05-09-2025
  • RDFN 05-06-2025
  • Dividend Yield
  • NVAX N/A
  • RDFN N/A
  • EPS Growth
  • NVAX N/A
  • RDFN N/A
  • EPS
  • NVAX N/A
  • RDFN N/A
  • Revenue
  • NVAX $682,162,000.00
  • RDFN $1,042,979,000.00
  • Revenue This Year
  • NVAX N/A
  • RDFN $2.40
  • Revenue Next Year
  • NVAX $15.02
  • RDFN $6.84
  • P/E Ratio
  • NVAX N/A
  • RDFN N/A
  • Revenue Growth
  • NVAX N/A
  • RDFN 6.79
  • 52 Week Low
  • NVAX $3.81
  • RDFN $5.10
  • 52 Week High
  • NVAX $23.86
  • RDFN $15.29
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.30
  • RDFN 67.01
  • Support Level
  • NVAX $7.66
  • RDFN $9.20
  • Resistance Level
  • NVAX $8.48
  • RDFN $10.47
  • Average True Range (ATR)
  • NVAX 0.64
  • RDFN 0.64
  • MACD
  • NVAX 0.08
  • RDFN 0.40
  • Stochastic Oscillator
  • NVAX 71.43
  • RDFN 97.23

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About RDFN Redfin Corporation

Redfin Corp is a residential real estate broker. It pairs its agents with the technology to create a service that is faster and costs less. The company meets customers through a listings-search website and mobile application. The company uses the same combination of technology and local service to originate mortgage loans and offer title and settlement services. It has five operating segments and three reportable segments, real estate services, rentals, and mortgage. The company generates the majority of its revenue from Real estate services.

Share on Social Networks: